<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01353092</url>
  </required_header>
  <id_info>
    <org_study_id>26.04.2010</org_study_id>
    <nct_id>NCT01353092</nct_id>
  </id_info>
  <brief_title>Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression</brief_title>
  <acronym>PEMFII</acronym>
  <official_title>PEMF Treatment in Patients With Treatment Resistant Depression in On-going Antidepressant Drug Therapy. A Randomized, Double-blind, Clinically Controlled, Dose-response PEMF Trial for a Duration of Eight Weeks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillerod Hospital, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillerod Hospital, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study patients with treatment resistant depression, as defined by Harold Sackeim, is
      subjected to daily sessions, for eight weeks, with Pulsating ElectroMagnetive Treatment
      (PEMF). Treatment is given two times a day, in the morning and in the afternoon. Patients are
      randomized into two groups. In group A patients receive active treatment both morning and
      afternoon. In group B patients receive one sham and one active treatment. The study is
      double-blind as neither the assessors or patients are aware of treatment allocation. Each
      session lasts 30 minutes. Patients are psychometrically assessed weekly for depression
      severity and side effect. After this intervention period patients are followed for further
      three weeks without PEMF treatment. Patients are on unchanged medication for the whole of the
      study period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton depression rating scale</measure>
    <time_frame>Every week for 11 weeks</time_frame>
    <description>Interviewer based rating scale to measure severity of depression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>UKU</measure>
    <time_frame>Every week for 11 weeks</time_frame>
    <description>Side effect scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Treatment Resistant Depression</condition>
  <arm_group>
    <arm_group_label>Active PEMF twice daily</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Re5 treatment helmet using Pulsating ElectroMagnetic Field:
Intervention: 30 minutes of active PEMF therapy in the morning and 30 minutes of active PEMF therapy in the afternoon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active PEMF once daily</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Re5 treatment helmet using Pulsating ElectroMagnetic Field:
Intervention: 30 minutes of sham therapy and 30 minutes of active therapy (morning or afternoon)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Re5 Pulsating ElectroMagnetic Fields</intervention_name>
    <description>Re5 Treatment Helmet using Pulsating ElectroMagnetic Fields (PEMF):
30 minutes of active PEMF therapy in the morning and 30 minutes of active PEMF therapy in the afternoon</description>
    <arm_group_label>Active PEMF twice daily</arm_group_label>
    <other_name>T-PEMF = Transcranially applied PEMF</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Re5 Pulsating ElectroMagnetic Fields (PEMF)</intervention_name>
    <description>Re5 Treatment Helmet using Pulsating ElectroMagnetic Fields (PEMF):
30 minutes of sham therapy and 30 minutes of active therapy (morning or afternoon)</description>
    <arm_group_label>Active PEMF once daily</arm_group_label>
    <other_name>T-PEMF = Transcranially applied PEMF</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Treatment resistant Major depression (grade 3 Sackeim criteria)

          -  Age above 18 and below 85

          -  Hamilton (17 item version) score above 12

          -  Unchanged psychopharmacological treatment for last five weeks.

        Exclusion Criteria:

          -  suicidality above 2 on item three on Hamilton scale or,earlier PEMF treatment

          -  dementia or similar cognitive impairment

          -  psychotic disorder

          -  abuse of alcohol or drugs

          -  pregnant or lactating women

          -  insufficient birth control measures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marianne Lunde, Coordinator</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mental Health Centre North Zealand Psychiatric Research Unit</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Psychiatric Research Unit, Mental Health Centre North Zealand</name>
      <address>
        <city>Hilleroed</city>
        <zip>3400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Martiny K, Lunde M, Bech P. Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression. Biol Psychiatry. 2010 Jul 15;68(2):163-9. doi: 10.1016/j.biopsych.2010.02.017. Epub 2010 Apr 10.</citation>
    <PMID>20385376</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2011</study_first_submitted>
  <study_first_submitted_qc>May 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2011</study_first_posted>
  <last_update_submitted>August 25, 2015</last_update_submitted>
  <last_update_submitted_qc>August 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hillerod Hospital, Denmark</investigator_affiliation>
    <investigator_full_name>Per Bech</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Major depression</keyword>
  <keyword>Hamilton</keyword>
  <keyword>PEMF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

